These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 27818386)

  • 41. Treatment experience of Taiwanese patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy.
    Liang WC; Wang CH; Chen WZ; Kuo YT; Lin HF; Suzuki S; Nishino I; Jong YJ
    Kaohsiung J Med Sci; 2020 Aug; 36(8):649-655. PubMed ID: 32666706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase].
    Hinschberger O; Lohmann C; Lannes B; Martzolff L; Vo BD; Jaeger-Bizet F; Ciobanu E; Kieffer P
    Rev Med Interne; 2014 Aug; 35(8):546-9. PubMed ID: 23910221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identifying statin-associated autoimmune necrotizing myopathy.
    Albayda J; Christopher-Stine L
    Cleve Clin J Med; 2014 Dec; 81(12):736-41. PubMed ID: 25452351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
    Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A
    Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
    Kishi T; Rider LG; Pak K; Barillas-Arias L; Henrickson M; McCarthy PL; Shaham B; Weiss PF; Horkayne-Szakaly I; Targoff IN; Miller FW; Mammen AL;
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1088-1094. PubMed ID: 28129483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atypical skin conditions of the neck and back as a dermal manifestation of anti-HMGCR antibody-positive myopathy.
    Kurashige T; Nakamura R; Murao T; Mine N; Sato M; Katsumata R; Kanaya Y; Dodo Y; Sugiura T; Ohshita T
    BMC Immunol; 2024 May; 25(1):30. PubMed ID: 38734636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anti-HMG-CoA reductase necrotizing myopathy: A report of 4 cases].
    Marti J; Kolev I; Lorleac'h A; Besnard S; Pihan M; Marcorelles P
    Rev Med Interne; 2017 Apr; 38(4):228-234. PubMed ID: 27876175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series.
    Tiniakou E; Rivera E; Mammen AL; Christopher-Stine L
    Arthritis Rheumatol; 2019 Oct; 71(10):1723-1726. PubMed ID: 31058470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody-positive necrotizing autoimmune myopathy with dermatomyositis-like eruption.
    Parikh P; Tavee J; Soltanzadeh P; Mammen AL; McKeever P; Li Y
    Muscle Nerve; 2018 Jun; 57(6):E135-E136. PubMed ID: 29346706
    [No Abstract]   [Full Text] [Related]  

  • 50.
    Bergua C; Chiavelli H; Allenbach Y; Arouche-Delaperche L; Arnoult C; Bourdenet G; Jean L; Zoubairi R; Guerout N; Mahler M; Benveniste O; Drouot L; Boyer O
    Ann Rheum Dis; 2019 Jan; 78(1):131-139. PubMed ID: 30309969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent focal myositis developing into a generalised idiopathic inflammatory myopathy with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies.
    Lim J; Ten Dam L; Baars PA; Van der Kooi AJ
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31678918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peculiar clinicopathological features of immune-mediated necrotizing myopathies.
    Allenbach Y; Benveniste O
    Curr Opin Rheumatol; 2018 Nov; 30(6):655-663. PubMed ID: 30239349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
    Mohassel P; Mammen AL
    Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories.
    Alvarado-Cardenas M; Marin-Sánchez A; Martínez MA; Martínez-Martínez L; Pinal-Fernandez I; Labrador-Horrillo M; Balada E; Mundet-Tuduri X; Gonzalez-Mera L; Casademont J; Acebes EM; Moreno PJ; Juarez C; Grau-Junyent JM; Pujol-Borrell R; Selva-O'Callaghan A
    Autoimmun Rev; 2016 Dec; 15(12):1161-1166. PubMed ID: 27640317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer.
    Mizuma A; Kouchi M; Netsu S; Yutani S; Kitao R; Suzuki S; Murata K; Nagata E; Takizawa S
    Intern Med; 2017; 56(14):1915-1918. PubMed ID: 28717093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-HMGCR antibodies and asymptomatic hyperCKemia. A case report.
    Torri F; Ali G; Chico L; Siciliano G; Ricci G
    Acta Myol; 2021 Jun; 40(2):105-108. PubMed ID: 34355128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects.
    Mammen AL; Pak K; Williams EK; Brisson D; Coresh J; Selvin E; Gaudet D
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):269-72. PubMed ID: 21972203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.
    Kassardjian CD; Lennon VA; Alfugham NB; Mahler M; Milone M
    JAMA Neurol; 2015 Sep; 72(9):996-1003. PubMed ID: 26192196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinicopathological Features of Myositis and Necrotizing Myopathy: How to Distinguish between Myositis and Muscular Dystrophy on Muscle Pathology].
    Saito Y; Nishino I
    Brain Nerve; 2021 Feb; 73(2):147-159. PubMed ID: 33561829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.